Navigation Links
InterMune to Present at the SIGnificant Options in Healthcare Conference
Date:2/28/2008

BRISBANE, Calif., Feb. 28 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Steven Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at Susquehanna's Second Annual SIGnificant Options in Healthcare Conference in New York on March 5, 2008 at 2:30 p.m. EST.

To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (R7227) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.

Forward-Looking Statements

Except for the historical information contained herein, this press release contains ce
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
7. Avicena Group to Present at Noble Financial Conference
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CEL-SCI to Present at the Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... Ernst & Young LLP ("EY") that it was resigning effective ... delivered to the Company on September 15, 2014 and reported ... PDL has issued the following statement in response ... of inquiries on the reason for the resignation of EY.  ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... TRIANGLE PARK, N.C. , Sept. 17, 2014 /PRNewswire/ ... and presentation topics that will be featured at the ... Hamner Conference Center on December 3 and 4, 2014. ... managers are invited to hear the following: ... PhD UC San Diego Skaggs School of ...
(Date:9/17/2014)... Shimadzu Scientific Instruments introduces ... which offers a powerful separation method for ... provides a new level of knowledge and ... to scientists analyzing pharmaceutical impurities, proteins, lipids, ... Comprehensive 2D-LC combines two independent separation modes ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... NEW YORK, Sept. 25 Bion Environmental Technologies,Inc. (OTC ... its patent application entitled, "Low Oxygen Organic Waste,Bioconversion System" ... and given a Standard Patent number of 2002227224. The,official ... the patent will be,in force until an expiration date ...
... for Neptune Technologies ... in FUNCTIONAL FOOD market-- ... ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today,that it entered a worldwide ... with Weider Global Nutrition for the distribution,of dietary supplements and ...
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... today the appointment of Cato T.,Laurencin, M.D., Ph.D. to ... Directors effective September 24, 2008 and will serve on ... of Directors., Kenneth P. Fallon, III, Chairman of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2
(Date:9/18/2014)... racial and ethnic groups describe losing eyesight as ... life, more so than other conditions including: loss ... African-Americans, 49% of non-Hispanic whites, 43% of Asians ... or ailment is the worst that could happen ... by AIDS/HIV. Hispanics and Asians ranked cancer ...
(Date:9/18/2014)... algal forests in the eastern Mediterranean Sea pose a ... distribution continues to expand as the climate warms, a ... of researchers led by Dr Adriana Vergs of UNSW ... for Advanced Studies in Spain, is published in the ... surveyed more than 1000 kilometres of coastline in Turkey ...
(Date:9/18/2014)... that when people are too stressed they are often ... Brain Mind Institute (BMI) at EPFL have just highlighted ... chronic stress and the loss of social skills and ... a synaptic regulatory molecule in the brain. This was ... . , Carmen Sandi,s team went to look ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Tropical fish a threat to Mediterranean Sea ecosystems 2How stress tears us apart 2
... Antonio Medical mycologists in The South Texas Center ... Biology at The University of Texas at San Antonio ... Valley Fever, a respiratory infection of humans, commonly called ... fungus. For the first time, the researchers ...
... is based on detecting short, repetitive DNA segments in ... such characteristic repeats. "With this method we are able ... genetic relationships. Furthermore, we can show how new pathogenic ... The results have now been published in the current ...
... New Orleans residents were told to evacuate days before the ... real extent of the devastation. Now researchers from ... reliable way to help predict the intensity of the next ... States. Their model, which analyzes cell phone signals, adds a ...
Cached Biology News:UTSA infectious disease researchers advancing vaccine against Valley fever 2The tiny difference in the genes of bacteria 2Hurricane Katrina: Phone home 2
... DIGIVIEW line of digital x-ray detectors from ... device complete with 12 to 16 bit ... of a photodiode array sensor with pixel ... are available in low x-ray energies (10-50 ...
The Odyssey Infrared Imaging System is a complete family of products that includes the Odyssey Imager, IRDye labeling reagents and Odyssey software for scan control and data analysis....
... System from KUBTEC is a dual capability system ... dimensional representation of the specimen under test. While ... X-ray images, the micro focus source also allows ... in standard 2D images. The 50 mm x ...
... the condition in which a lack of ... the various antioxidants. Oxidative stress appears ... several diseases, including artherosclerosis, chronic inflammatory diseases, ... antioxidant systems that are very important for ...
Biology Products: